Loading clinical trials...

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture | Clinical Trials | Clareo Health

RECRUITINGPHASE4

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture

NCT06278987•University of Minnesota

View on ClinicalTrials.gov

Summary

The purpose of this study is to determine if patients with hip fractures who undergo cryoablation of the PENG have improved pain control 30 days from surgery when compared to those who have a fascia iliaca catheter.

Eligibility

Age

18 - 85 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients undergoing hip fracture repair aged 18-85.

Exclusion Criteria

•Patients who have an exclusion to regional anesthesia.
•Patients who are pregnant assessed via self-report or pregnancy test if they have taken one.
•Non-English speakers
•Patients who already had their fracture repaired"

Locations (1)

University of Minnesota

Minneapolis, Minnesota, United States

Key Dates

Start Date

October 1, 2024

Primary Completion Date

October 1, 2026

Completion Date

October 1, 2027

Last Updated

November 25, 2025

Enrollment

150

ESTIMATED participants

Conditions

Hip Fractures

Interventions

PENG block and cryoablation

DRUG

fascia iliaca compartment block

DRUG

Contacts

Candace Nelson

CONTACT

nelso377@umn.edu

Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

NCT06565910

Femoral Neck FracturesFemur Head Necrosis+1 more

View study

RECRUITINGNA

One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures

NCT07432737

Hip Fractures

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 25, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Comparison of Cryoablation of Pericapsular Nerve Group (PENG) to Fascia Iliaca Catheter in Patients With a Hip Fracture

Inclusion Criteria

Exclusion Criteria

Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG)

One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures

Evaluation of Fracture Migration After Internal Fixation of Femoral Neck Fractures in Younger Adults: A Clinical RCT Using RSA

HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial

PENG vs Femoral Block for Hip Fracture Analgesia

Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion